Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Needle Free Injection System Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Needle-Free Injection System Market Trends and Forecast

The future of the needle-free injection system market looks promising with opportunities in the hospitals and clinics, homecare settings, research laboratories, pharmaceutical and biotechnology companies. The global needle-free injection system market is expected to reach an estimated $6 billion by 2030 with a CAGR of 15% from 2023 to 2030. The major drivers for this market are growing prevalence of chronic diseases, the increasing incidence of communicable diseases due to needle stick injuries, and rise in demand for self-injection devices.
Needle-Free Injection System Market

Country wise Outlook for the Needle-Free Injection System Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below image highlights recent developments by major needle-free injection system producers in key regions: the USA, Germany, China, South Korea, and India.
Needle-Free Injection System Market by Country

Emerging Trends in Needle-Free Injection System Market

Emerging trends which have a direct impact on the dynamics of the needle-free injection system industry include introduction of bubble gun and usage of highly-focused liquid micro-jets for needle-free injection systems.
1. Technological Advancements: Innovations in technology are leading to the development of more efficient, safer, and user-friendly needle-free injection systems. These advancements include improved precision in drug delivery, better control over injection depth, and integration with smart technologies for monitoring and compliance.
2. Increasing Demand for Pain-Free Drug Delivery: There is a growing preference for pain-free and minimally invasive drug delivery methods among patients. Needle-free injection systems offer a solution to needle phobia and reduce the discomfort associated with traditional injections, making them more appealing to both patients and healthcare providers.
3. Rise in Chronic Diseases: The increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and cardiovascular diseases is boosting the demand for self-administration drug delivery systems. Needle-free injection systems provide a convenient and efficient method for regular drug administration, enhancing patient adherence to treatment regimens.
4. Expanding Applications: Needle-free injection systems are being used for a broader range of applications, including vaccination, hormone therapy, and cosmetic treatments. The versatility of these systems is expanding their adoption across various medical fields.
5. Growing Biopharmaceutical Industry: The rise of biologics and biosimilars is driving the need for advanced drug delivery systems. Needle-free injection systems are particularly suitable for the delivery of biologic drugs, which often require precise dosing and frequent administration.

Needle-Free Injection System Market Emerging Trend

A more than 150-page report to help in your business decisions. Sample figures with some insights are shown below.
Needle-Free Injection System Market by Segments

Recent Developments in the Needle-Free Injection System Market

Recent developments in the needle-free injection system market are being driven by advancements in technology, increased demand for painless and efficient drug delivery methods, regulatory approvals, and strategic initiatives by key players. Here are the key trends and updates:
Technological Advancements:
• Advanced Delivery Mechanisms: Innovations in propulsion technologies, such as gas-powered, spring-powered, and jet injection systems, are enhancing the precision and efficiency of needle-free injections.
• Improved Formulations: Development of drugs specifically formulated for needle-free delivery to ensure stability and efficacy when administered through these systems.
• Digital Integration: Integration of digital health technologies, such as smart sensors and connectivity features, to monitor and track injection usage and adherence.
Market Demand Shifts:
• Patient Preference: Growing preference for needle-free injection systems among patients due to reduced pain, fear of needles, and lower risk of needlestick injuries.
• Vaccination Programs: Increased use of needle-free systems in mass vaccination programs, especially for pandemics like COVID-19, to improve compliance and reduce logistical challenges.
Regulatory Approvals:
• FDA and CE Approvals: Several needle-free injection systems have received regulatory approvals, facilitating their adoption in various medical applications, including insulin delivery, vaccination, and hormone therapy.
• Guidelines and Standards: Development of regulatory guidelines and standards to ensure the safety, efficacy, and quality of needle-free injection systems.
Strategic Partnerships and Acquisitions:
• Collaborations: Partnerships between needle-free injection system manufacturers and pharmaceutical companies to co-develop and commercialize needle-free drug delivery solutions.
• Mergers and Acquisitions: Industry consolidation through acquisitions to enhance product portfolios, expand market presence, and leverage technological synergies.
Market Expansion:
• Geographic Expansion: Expansion of needle-free injection systems into emerging markets in Asia-Pacific, Latin America, and Africa, driven by increasing healthcare access and demand for advanced medical technologies.
• New Applications: Exploration of new therapeutic areas and applications for needle-free injection systems, such as oncology, pain management, and dermatology.
The needle-free injection system market is poised for significant growth, driven by technological advancements, increasing patient preference for painless drug delivery methods, and strategic initiatives by key players. Ongoing innovations and regulatory support are likely to shape the future of this market, making needle-free injections a mainstream method of drug delivery in various medical applications.

Strategic Growth Opportunities for Needle-Free Injection System Market

• Rising Demand for Home Healthcare
Increasing trend towards home-based healthcare solutions opens opportunities for needle-free injection systems, making it easier for patients to self-administer medication.
• Growth in Biologics and Biosimilars
The expanding market for biologic drugs, which often require precise delivery methods, presents significant opportunities for needle-free technologies.
• Technological Advancements
Continuous innovation in device design, including improvements in drug delivery mechanisms and user-friendly interfaces, can drive market adoption and differentiation.
• Emerging Markets
Expansion into developing regions with growing healthcare infrastructures can provide new avenues for needle-free injection system adoption, especially in vaccination programs.
• Regulatory Support
Supportive regulatory frameworks promoting safer injection practices can enhance the growth of needle-free systems, encouraging manufacturers to invest in this technology.
The needle-free injection system market presents significant growth opportunities driven by technological advancements, the demand for safer healthcare solutions, and evolving market needs. By leveraging these opportunities through innovation, partnerships, and education, companies can strengthen their market position and address the increasing demand for efficient drug delivery systems.

Needle-Free Injection System Market Driver and Challenges

Drivers in the Needle-Free Injection System Market
1. Increased Demand for Patient Comfort: Needle-free systems provide a less painful and more comfortable alternative to traditional injections, appealing to both patients and healthcare providers.
2. Rising Incidence of Needle-Related Injuries: Growing awareness of needle-stick injuries and associated infections drives the demand for safer injection methods.
3. Technological Advancements: Innovations in needle-free technology, including improved delivery mechanisms and devices, enhance the effectiveness and reliability of these systems.
4. Focus on Chronic Disease Management: Increasing prevalence of chronic diseases, such as diabetes, necessitates regular medication administration, making needle-free systems more attractive for patients.
5. Growth of Biologics and Vaccines: The rising use of biologics and vaccines that require consistent delivery methods supports the adoption of needle-free injection systems.
Challenges in the Needle-Free Injection System Market
1. High Initial Costs: The upfront costs associated with purchasing needle-free injection systems can be higher than traditional methods, which may deter some healthcare providers.
2. Limited Awareness and Acceptance: Lack of awareness and familiarity with needle-free systems among healthcare professionals and patients can hinder widespread adoption.
3. Technological Limitations: Some needle-free injection systems may face challenges related to dosage accuracy, device reliability, and the potential for inconsistent delivery.
4. Regulatory Hurdles: Navigating complex regulatory approvals and compliance can be time-consuming and costly for manufacturers.
5. Market Competition: Intense competition from established players and alternative drug delivery methods can impact market share and pricing strategies.
The needle-free injection system market is driven by the demand for safer and more comfortable delivery methods, but it faces challenges related to costs, awareness, and regulatory complexities. Addressing these challenges while leveraging growth drivers will be crucial for success in this evolving market.

Needle-Free Injection System Suppliers and their Market Shares

In this globally competitive market, several key players such as Endo International plc, Ferring Pharmaceuticals, Penjet Corporation, Medical International Technology Inc., PharmaJet, etc. dominate the market and contribute to industry’s growth and innovation. These players capture maximum market share. To know the current market share of each of major players contact us.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, needle-free injection system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the needle-free injection system companies profiled in this report include-
• Endo International plc
• Ferring Pharmaceuticals
• Penjet Corporation
• Medical International Technology Inc.
• PharmaJet
These companies have established themselves as leaders in the needle-free injection system, with extensive product portfolios, global presence, and strong research and development capabilities. They continually strive to enhance their market positions through strategic partnerships, mergers and acquisitions, and product innovations.
The market share dynamics within the needle-free injection system market are evolving, with the entry of new players and the emergence of innovative needle-free injection system. Additionally, collaborations between material suppliers, manufacturers, and end-users are fostering technological advancements and expanding market opportunities.

Needle-Free Injection System Market by Segment

The major segment of needle-free injection systems that is experiencing significant growth is in the healthcare and pharmaceutical sectors, particularly for vaccine delivery. Needle-free injectors are gaining popularity due to their ability to deliver vaccines painlessly and effectively, enhancing patient comfort and compliance. This segment is driven by increasing immunization efforts globally, where needle-free technology offers advantages such as reduced needle phobia, improved safety by eliminating needle stick injuries, and potential cost savings in healthcare settings. Moreover, advancements in microfluidics, biotechnology, and regulatory approvals are further accelerating the adoption of needle-free injection systems in healthcare applications, positioning it as a prominent growth area within the medical device industry.
This needle-free injection systems market report provides a comprehensive analysis of the market's current trends, growth drivers, challenges, and future prospects in all major segments like above. It covers various segments, including product, technology, usability, type of medication, site of delivery, application, and end users. The report offers insights into regional dynamics, highlighting the major markets for needle free injection system and their growth potentials. The study includes trends and forecast for the global needle-free injection systems market by product, technology, usability, type of medication, site of delivery, application, end users and region as follows:

Needle-Free Injection System Market by Product [Value ($ Million) from 2018 – 2030]:


• Fillable Needle-Free Injectors
• Prefilled Needle-Free Injectors

Needle-Free Injection System Market by Technology [Value ($ Million) from 2018 – 2030]:


• Jet-Based Needle-Free Injector
• Spring-Based Needle-Free Injector
• Laser-Based Needle-Free Injector
• Vibration-Based Needle-Free Injector

Needle-Free Injection System Market by Usability [Value ($ Million) from 2018 – 2030]:


• Reusable Needle-Free Injectors
• Disposable Needle-Free Injectors

Needle-Free Injection System Market by Type of Medication [Value ($ Million) from 2018 – 2030]:


• Liquid-Based Needle-Free Injectors
• Powder-Based Needle-Free Injectors
• Projectile/Depot-Based Needle-Free Injectors

Needle-Free Injection System Market by Site of Delivery [Value ($ Million) from 2018 – 2030]:


• Intradermal Injectors
• Intramuscular Injectors
• Subcutaneous Injectors

Needle-Free Injection System Market by Application [Value ($ Million) from 2018 – 2030]:

• Vaccine Needle-Free Delivery
• Insulin Needle-Free Delivery
• Pain Management Needle-Free Delivery
• Oncology Needle-Free Delivery
• Others

• Hospitals and Clinics<br />• Homecare Settings<br />• Research Laboratories<br />• Pharmaceutical and Biotechnology Companies<br />• Others<br />

Features of the Global Needle-Free Injection System Market

• Market Size Estimates: Global needle-free injection system market size estimation in terms of value ($M).
• Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments.
• Segmentation Analysis: Global needle-free injection system market size by product, technology, usability, type of medication, site of delivery, application, end user, and region in terms of value.
• Regional Analysis: Global needle-free injection system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different by product, technology, usability, type of medication, site of delivery, application, end user, and region for the global needle-free injection system market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global needle-free injection system market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in needle free injection system or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1. What are some of the most promising growth opportunities for the global needle-free injection system market by product (fillable needle-free injectors and prefilled needle-free injectors), technology (jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors, and vibration-based needle-free injectors), usability (reusable and disposable needle-free injectors), type of medication (liquid-based needle-free injectors, powder-based needle-free injectors, and projectile/depot-based needle-free injectors), site of delivery (intradermal injectors, intramuscular injectors, and subcutaneous injectors), application (vaccine needle-free delivery, insulin needle-free delivery, pain management needle-free delivery, oncology needle-free delivery, and others), end users (hospitals and clinics, homecare settings, research laboratories, pharmaceutical and biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the global needle-free injection system market?
Q.5. What are the business risks and threats to the global needle-free injection system market?
Q.6. What are the emerging trends in this needle-free injection system market and the reasons behind them?
Q.7. What are some changing demands of customers in the needle-free injection system market?
Q.8. What are the new developments in the needle-free injection system market? Which companies are leading these developments?
Q.9. Who are the major players in the needle-free injection system market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in the needle-free injection system market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M&A activities did take place in the last five years in the global needle-free injection system market?

For any questions related to needle-free injection system market or related to needle-free injection system companies, needle-free injection system market share, needle-free injection system market analysis, and needle-free injection system market size, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.

This report answers following 11 key questions

Q.1. What are some of the most promising growth opportunities for the global needle-free injection system market by product (fillable needle-free injectors and prefilled needle-free injectors), technology (jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors, and vibration-based needle-free injectors), usability (reusable and disposable needle-free injectors), type of medication (liquid-based needle-free injectors, powder-based needle-free injectors, and projectile/depot-based needle-free injectors), site of delivery (intradermal injectors, intramuscular injectors, and subcutaneous injectors), application (vaccine needle-free delivery, insulin needle-free delivery, pain management needle-free delivery, oncology needle-free delivery, and others), end users (hospitals and clinics, homecare settings, research laboratories, pharmaceutical and biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the global needle-free injection system market?
Q.5. What are the business risks and threats to the global needle-free injection system market?
Q.6. What are the emerging trends in this needle-free injection system market and the reasons behind them?
Q.7. What are some changing demands of customers in the needle-free injection system market?
Q.8. What are the new developments in the needle-free injection system market? Which companies are leading these developments?
Q.9. Who are the major players in the needle-free injection system market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in the needle-free injection system market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M&A activities did take place in the last five years in the global needle-free injection system market?

For any questions related to needle-free injection system market or related to needle-free injection system companies, needle-free injection system market share, needle-free injection system market analysis, and needle-free injection system market size, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
 

Table of Contents

1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2016 to 2027
3.1: Macroeconomic Trends and Forecast
3.2 Global Needle-Free Injection System Market Trends and Forecast
3.3: Global Needle-Free Injection System Market by Product Type
3.3.1: Fillable Needle-Free Injectors
3.3.2: Prefilled Needle-Free Injectors
3.4: Global Needle-Free Injection System Market by Technology
3.4.1 Jet-Based Needle-Free Injectors
3.4.2 Spring-Based Needle-Free Injectors
3.4.3 Laser-Powered Needle-Free Injectors
3.4.4 Vibration-Based Needle-Free Injectors
3.5 Global Needle-Free Injection System Market by Usability
3.5.1 Reusable Needle-Free Injectors
3.5.2 Disposable Needle-Free Injectors
3.6 Global Needle-Free Injection System Market by Type of Medication
3.6.1 Liquid-Based Needle-Free Injectors
3.6.2 Powder-Based Needle-Free Injectors
3.6.3 Projectile/Depot-Based Needle-Free Injectors
3.7 Global Needle-Free Injection System Market by Site of Delivery
3.7.1 Intradermal Needle-Free Injectors
3.7.2 Intramuscular Needle-Free Injectors
3.7.3 Subcutaneous Needle-Free Injectors
3.8 Global Needle-Free Injection System Market by Application
3.8.1 Vaccine Needle-Free Delivery
3.8.2 Insulin Needle-Free Delivery
3.8.3 Pain Management Needle-Free Delivery
3.8.4 Oncology Needle-Free Delivery
3.8.5 Others
3.9 Global Needle-Free Injection System Market by End User
3.9.1 Hospitals and Clinics
3.9.2 Homecare Settings
3.9.3 Research Laboratories
3.9.4 Pharmaceutical and Biotechnology Companies
3.9.5 Others

4. Market Trends and Forecast Analysis by Region
4.1: Global Needle-Free Injection System Market by Region
4.2: North American Needle-Free Injection System Market
4.2.1: Market by Product Type: Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors
4.2.2: Market by Technology: Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Based Needle-Free Injectors, and Vibration-Based Needle-Free Injectors
4.2.3: Market by Usability: Reusable Needle-Free Injectors and Disposable Needle-Free Injectors
4.2.4: Market by Type of Medication: Liquid-Based Needle-Free Injectors, Powder-Based Needle-Free Injectors, and Projectile/Depot-Based Needle-Free Injectors
4.2.5: Market by Site of Delivery: Intradermal Injectors, Intramuscular Injectors, and Subcutaneous Injectors
4.2.6: Market by Application: Vaccine Needle-Free Delivery, Insulin Needle-Free Delivery, Pain Management Needle-Free Delivery, Oncology Needle-Free Delivery, and Others
4.2.7: Market by End User: Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology Companies, and Others
4.2.8: The US Needle-Free Injection System Market
4.2.9: Canadian Needle-Free Injection System Market
4.2.10: Mexican Needle-Free Injection System Market
4.3: European Needle-Free Injection System Market
4.3.1: Market by Product Type: Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors
4.3.2: Market by Technology: Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Based Needle-Free Injectors, and Vibration-Based Needle-Free Injectors
4.3.3: Market by Usability: Reusable Needle-Free Injectors and Disposable Needle-Free Injectors
4.3.4: Market by Type of Medication: Liquid-Based Needle-Free Injectors, Powder-Based Needle-Free Injectors, and Projectile/Depot-Based Needle-Free Injectors
4.3.5: Market by Site of Delivery: Intradermal Injectors, Intramuscular Injectors, and Subcutaneous Injectors
4.3.6: Market by Application: Vaccine Needle-Free Delivery, Insulin Needle-Free Delivery, Pain Management Needle-Free Delivery, Oncology Needle-Free Delivery, and Others
4.3.7: Market by End User: Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology Companies, and Others
4.3.8: German Needle-Free Injection System Market
4.3.9: French Needle-Free Injection System Market
4.3.10: Needle-Free Injection System Market of the United Kingdom
4.3.11: Italian Needle-Free Injection System Market
4.3.12: Spanish Needle-Free Injection System Market
4.4: APAC Needle-Free Injection System Market
4.4.1: Market by Product Type: Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors
4.4.2: Market by Technology: Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Based Needle-Free Injectors, and Vibration-Based Needle-Free Injectors
4.4.3: Market by Usability: Reusable Needle-Free Injectors and Disposable Needle-Free Injectors
4.4.4: Market by Type of Medication: Liquid-Based Needle-Free Injectors, Powder-Based Needle-Free Injectors, and Projectile/Depot-Based Needle-Free Injectors
4.4.5: Market by Site of Delivery: Intradermal Injectors, Intramuscular Injectors, and Subcutaneous Injectors
4.4.6: Market by Application: Vaccine Needle-Free Delivery, Insulin Needle-Free Delivery, Pain Management Needle-Free Delivery, Oncology Needle-Free Delivery, and Others
4.4.7: Market by End User: Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology Companies, and Others
4.4.8: Japanese Needle-Free Injection System Market
4.4.9: Chinese Needle-Free Injection System Market
4.4.10: Indian Needle-Free Injection System Market
4.5: ROW Needle-Free Injection System Market
4.5.1: Market by Product Type: Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors
4.5.2: Market by Technology: Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Based Needle-Free Injectors, and Vibration-Based Needle-Free Injectors
4.5.3: Market by Usability: Reusable Needle-Free Injectors and Disposable Needle-Free Injectors
4.5.4: Market by Type of Medication: Liquid-Based Needle-Free Injectors, Powder-Based Needle-Free Injectors, and Projectile/Depot-Based Needle-Free Injectors
4.5.5: Market by Site of Delivery: Intradermal Injectors, Intramuscular Injectors, and Subcutaneous Injectors
4.5.6: Market by Application: Vaccine Needle-Free Delivery, Insulin Needle-Free Delivery, Pain Management Needle-Free Delivery, Oncology Needle-Free Delivery, and Others
4.5.7: Market by End User: Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology Companies, and Others
4.5.8: Brazilian Needle-Free Injection System Market

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Geographical Reach
5.4: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Needle-Free Injection System Market by Product Type
6.1.2: Growth Opportunities for the Global Needle-Free Injection System Market by Technology
6.1.3: Growth Opportunities for the Global Needle-Free Injection System Market by Usability
6.1.4: Growth Opportunities for the Global Needle-Free Injection System Market by Type of Medication
6.1.5: Growth Opportunities for the Global Needle-Free Injection System Market by Site of Delivery
6.1.6: Growth Opportunities for the Global Needle-Free Injection System Market by Application
6.1.7: Growth Opportunities for the Global Needle-Free Injection System Market by End User
6.1.8: Growth Opportunities for the Global Needle-Free Injection System Market by Region
6.2: Emerging Trends in the Global Needle-Free Injection System Market
6.3: Strategic Analysis
6.6.1: New Product Development
6.3.2: Mergers, Acquisitions, and Joint Ventures in the Global Needle-Free Injection System Market

7. Company Profiles of Leading Players
7.1: Ferring Pharmaceuticals
7.2: Endo International plc
7.3: PharmaJet
7.4: INJEX Pharma AG
7.5: PenJet Corporation
7.6: INOVIO
7.7: European Pharma Group BV
7.8: Zogenix Inc.
7.9: Crossject
7.10: Medical International Technology Inc.
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Needle Free Injection System Market: Trends, Opportunities and Competitive Analysis Full Report $ 4,850
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.